Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
about
Nitrosothiol signaling and protein nitrosation in cell deathATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFκB and STAT3 inhibition in glioblastomaSulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases.Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance.
P2860
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
@en
type
label
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
@en
prefLabel
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
@en
P2860
P1476
Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.
@en
P2093
Khosrow Kashfi
P2860
P304
P356
10.1615/FORUMIMMUNDISTHER.2012006099
P577
2012-01-01T00:00:00Z